Compound E, chemically designated as the compound 209986-17-4, represents a significant study within the field of Alzheimer's condition research. This γ-secretase modulator was initially developed as a promising https://prestonkhfb301415.blog-gold.com/57406341/γ-secretase-blocker-compound-e-209986-17-4